Oppimi proposes a complete solution to help diagnose and support an efficient Dysgraphia Treatment
LEARNING DISABILITIES DIGITAL SOLUTIONS
Innovative Learning Disabilities diagnosis and therapy process through AI and Gamification
VISION & PHILOSOPHY
At Oppimi we are using AI for creating innovative clinically-validated Digital Health Tools for diagnosing and treating children that are affected by learning disabilities, through video game environments.
Making test and therapy for learning disabilities as Dysgraphia, Dyslexia, Dyscalculia more efficient, easier and funnier is our main goal!
We are providing a full ecosystem that connects learning disabilities specialists, teachers and children’s parents, while given them access to test content and results, therapy advancement details and high-quality analytics.
World is moving fast and taking advantage of big data and sharing platforms can drastically fasten research and benefits children, families and science.
Oppimi Group, digital innovator in the field of Clinically validated tools for diagnosing and treating learning disabilities, announces a capital increase through private placement with Wygu Investment Holdings Co. Limited.
Getting the wheel rolling is a priority for Oppimi, now that core team is set up. We found in Pu-Ying Olicom the right investor, to make real things happen. We were looking for active investors that can help us extend our network, especially on China market. Great fit with Pu-Ying Olicom, who are very active in leveraging our entry into Asian market and accelerating research and development.
Start supporting children
Oppimi signed 2 years contract with Rotaract: Rotary Romania for the largest pilot phase of Oppimi’s Dysgraphia Platform. Thanks to Rotaract Volunteers, we will present our platform to Romanian schools and with them, on coming September 2017, we will start the first Oppimi Pilot in Europe.
Oppimi Group and Oppimi China are proud to announced a three-year research partnership with Beijing universities to unlock the potential of digital therapeutics in dyslogographia, dysgraphia applied to Chinese characters.
Oppimi Group, digital innovator in the field of Clinically validated tools for diagnosing and treating learning disabilities, announces a capital increase through private placement with Wygu Investment Holdings Co. Limited. Oppimi Group announces a capital increase in the form of a private placement. This capital increase by Wygu Investment Holdings Co. Limited comes 12 months […]
Exciting News! We’re thrilled to announce the appointment of Kim Tun Lau as Oppimi new Board Member. “We are excited to announce the addition of this very accomplished healthcare and pharmaceutical industries leader to Oppimi,” said Ervin Ukaj, Chairman and Chief Executive Officer of Oppimi. “His guidance and expertise will be instrumental as we continue […]
Having questions, need more information, interested in a partnership, please hit the button below